These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30030818)

  • 1. Severity-Stratified Discrete Choice Experiment Designs for Health State Evaluations.
    Lim S; Jonker MF; Oppe M; Donkers B; Stolk E
    Pharmacoeconomics; 2018 Nov; 36(11):1377-1389. PubMed ID: 30030818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of methods for converting DCE values onto the full health-dead QALY scale.
    Rowen D; Brazier J; Van Hout B
    Med Decis Making; 2015 Apr; 35(3):328-40. PubMed ID: 25398621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A framework for estimating health state utility values within a discrete choice experiment: modeling risky choices.
    Robinson A; Spencer A; Moffatt P
    Med Decis Making; 2015 Apr; 35(3):341-50. PubMed ID: 25349189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Value Set Based on DCE and/or TTO Data: Scoring for EQ-5D-5L Health States in Japan.
    Shiroiwa T; Ikeda S; Noto S; Igarashi A; Fukuda T; Saito S; Shimozuma K
    Value Health; 2016; 19(5):648-54. PubMed ID: 27565282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
    Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
    Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the Optimization of Bayesian D-Efficient Discrete Choice Experiment Designs for the Estimation of QALY Tariffs That Are Corrected for Nonlinear Time Preferences.
    Jonker MF; Bliemer MCJ
    Value Health; 2019 Oct; 22(10):1162-1169. PubMed ID: 31563259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do Discrete Choice Experiments Approaches Perform Better Than Time Trade-Off in Eliciting Health State Utilities? Evidence From SF-6Dv2 in China.
    Xie S; Wu J; He X; Chen G; Brazier JE
    Value Health; 2020 Oct; 23(10):1391-1399. PubMed ID: 33032784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Should Discrete Choice Experiments with Duration Choice Sets Be Presented for the Valuation of Health States?
    Mulhern B; Norman R; Shah K; Bansback N; Longworth L; Viney R
    Med Decis Making; 2018 Apr; 38(3):306-318. PubMed ID: 29084472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are Efficient Designs Used in Discrete Choice Experiments Too Difficult for Some Respondents? A Case Study Eliciting Preferences for End-of-Life Care.
    Flynn TN; Bilger M; Malhotra C; Finkelstein EA
    Pharmacoeconomics; 2016 Mar; 34(3):273-84. PubMed ID: 26589411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Test-Retest Reliability of EQ-5D-5L Valuation Techniques: The Composite Time Trade-Off and Discrete Choice Experiments.
    Purba FD; Hunfeld JAM; Timman R; Iskandarsyah A; Fitriana TS; Sadarjoen SS; Passchier J; Busschbach JJV
    Value Health; 2018 Oct; 21(10):1243-1249. PubMed ID: 30314626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Not all respondents use a multiplicative utility function in choice experiments for health state valuations, which should be reflected in the elicitation format (or statistical analysis).
    Jonker MF; Norman R
    Health Econ; 2022 Feb; 31(2):431-439. PubMed ID: 34841637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot discrete choice experiment to explore preferences for EQ-5D-5L health states.
    Norman R; Cronin P; Viney R
    Appl Health Econ Health Policy; 2013 Jun; 11(3):287-98. PubMed ID: 23649892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring Differences between TTO and DCE in the Valuation of Health States.
    Robinson A; Spencer AE; Pinto-Prades JL; Covey JA
    Med Decis Making; 2017 Apr; 37(3):273-284. PubMed ID: 27646566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Order of Presentation of Dimensions Does Not Systematically Bias Utility Weights from a Discrete Choice Experiment.
    Norman R; Kemmler G; Viney R; Pickard AS; Gamper E; Holzner B; Nerich V; King M
    Value Health; 2016 Dec; 19(8):1033-1038. PubMed ID: 27987630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Dimension Order Important when Valuing Health States Using Discrete Choice Experiments Including Duration?
    Mulhern B; Norman R; Lorgelly P; Lancsar E; Ratcliffe J; Brazier J; Viney R
    Pharmacoeconomics; 2017 Apr; 35(4):439-451. PubMed ID: 27873226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using a discrete choice experiment to estimate health state utility values.
    Bansback N; Brazier J; Tsuchiya A; Anis A
    J Health Econ; 2012 Jan; 31(1):306-18. PubMed ID: 22197308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discrete Choice Experiments in Health State Valuation: A Systematic Review of Progress and New Trends.
    Wang H; Rowen DL; Brazier JE; Jiang L
    Appl Health Econ Health Policy; 2023 May; 21(3):405-418. PubMed ID: 36997744
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.